期刊文献+

丙泊酚联合瑞芬太尼及右美托咪啶在无痛ESD术中的应用 被引量:1

Clinical Efficacy of Propofol with Remifentanil and Dexmedetomidine in Endoscopic Submucosal Dissection
下载PDF
导出
摘要 目的:评价丙泊酚联合瑞芬太尼及右美托咪啶在内镜黏膜下剥离术(ESD)麻醉中的有效性及安全性。方法:将麻醉下行胃ESD患者50例随机分为丙泊酚维持麻醉组(A组)、丙泊酚诱导右美托咪啶复合瑞芬太尼维持麻醉组(B组);记录给药前(T0)及给药后1min(T1)、5min(T2)、10min(T3)、20min(T4)、30min(T5)、40min(T6)时的HR、MAP、RR、SpO2,手术时间、苏醒时间、不良反应发生率、苏醒即刻下腹痛(VAS)及患者满意度。结果:所有病例均能顺利完成操作:(1)给药后A组T1-T3时点MAP、HR、RR较T0时点下降,T1-T2时点SpO2明显下降(P〈0.05)。给药后B组T1-T5时点HR较T0时点下降(P〈0.05)。(2)组间比较A组T2-T3时点MAP较B组下降(P〈0.05),而B组患者T2-T5时点HR明显低于同时间点A组患者,B组患者在T2时点心动过缓的发生率高于A组(P〈0.05)。(3)B组患者呼吸抑制、术中体动发生率、苏醒后下腹痛低于A组(P〈0.05)。B组苏醒时间短于A组(P〈0.05)。两组手术时间、术后恶心呕吐及患者满意度差异无统计学意义(P〉0.05)。结论:丙泊酚联合瑞芬太尼及右美托咪啶用于无痛ESD,是一种安全、有效、可行的麻醉方法。 Objective:To evaluate the effect and safety of propofol with remifentanil and dexmedetomidine in endoscopic submucosal dissection(ESD).Methods:Fifty patients undergoing anesthesia ESD were randomly divided into two groups:group A(25cases)was given maintained propofol;group B(25cases)was given induced dose of propofol,and followed with maintained dexmedetomidine and remifentanil.The following indexes were recorded:HR,MAP,RR,SpO2 at each time point before anesthesia and under operation,the time of operation and palinesthesia,the incidence of adverse reaction,VAS scores of hypogastralgia and patient satisfaction.Results:All patients were able to successfully complete the operation:(1)after administration,compared with T0 time point,HR,MAP,RR were significantly decreased at T1-T3time point,and SpO2 was significantly decreased at T1-T2time point in group A(P〈0.05).HR was significantly decreased at T1-T5in group B(P〈0.05).(2)Compared the two groups at the same time point,MAP was significantly decreased at T2-T3in group A(P〈0.05),HR was significantly decreased at T2-T5in group B(P〈0.05),and the incidence rate of beckoning bradycardia at T2 in group B was significantly high(P〈0.05).(3)The incidence rate of respiratory inhibition,body movement,hypogastralgia and emergence time was significantly lower in group B compared with group A(P〈0.05),and there were no significant difference between the operation time,the incidence of nausea and vomiting,and patient satisfaction in the two groups(P〉0.05).Conclusion:The anesthetic effect of propofol with remifentanil and dexmedetomidine for patients undergoing ESD is satisfactory and safe.
作者 朱丽 刘枫
出处 《医学理论与实践》 2015年第5期571-573,579,共4页 The Journal of Medical Theory and Practice
关键词 右美托咪啶 瑞芬太尼 丙泊酚 内镜黏膜下剥离术 Dexmedetomidine Remifentanil Propofol Endoscopic submucosal dissection(ESD)
  • 相关文献

参考文献2

二级参考文献45

  • 1[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 2[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 3[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 4[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 5[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 6[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 7[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 8[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
  • 9[9]Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000;93:382-394.
  • 10[10]Ramsey MA,Luterman DL.Dexmedetomidine as a total intravenous anesthestic agent[J].Anesthesiology,2004;101:787-781.

共引文献485

同被引文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部